On the Wednesday, April 15, 2026, episode of The Excerpt podcast: Prices for cutting-edge medical treatments can balloon in the U.S. health care system, leading to higher costs for the employer, ...

The gap between US drug prices and those abroad is not a market outcome — it is the result of deliberate political and ...

A yearlong international investigation into one of the world's most important cancer drugs shows how a medical breakthrough has also become a fault line in global health, exposing how pricing systems, ...

With at least seven Indian manufacturers in the race to develop generic versions of Merck & Co’s best-selling cancer immunotherapy drug Keytruda, doctors and researchers say a far cheaper alternative ...

President Donald Trump has repeatedly said his deals with drugmakers would bring down prescription drug prices in the U.S. But a report released by Senate Democrats finds prices have continued to ...

Mounjaro generated $8.7 billion for Lilly in the first quarter of 2026, outperforming Merck's Keytruda, which posted sales of $7.9 billion ...

The blockbuster cancer drug Keytruda can cost over $150,000 Merck & Co.'s Keytruda in the U.S. starts at $12,000 for a 200 mg dose. Costs go up from there based on the insurer, provider and middlemen ...